kenvue tylenol - Search News

Texas Sues Tylenol Makers

Who makes Tylenol? Who owns Kenvue? Texas sues Tylenol over alleged autism, Tylenol link

Texas Attorney General Ken Paxton is suing Tylenol makers Johnson & Johnson and its spinoff company Kenvue, claiming Tylenol failed to warn consumers about the possible link between Tylenol and autism...

· 16h · on MSN

Texas sues Tylenol makers J&J and Kenvue, claiming they hid drug's autism risks

· 22h · on MSN

Texas AG sues Kenvue, J&J over 'deceptively marketing' Tylenol to pregnant women

· 17h

Texas sues Tylenol companies over autism claims

Texas Attorney General Ken Paxton said Tuesday he will sue drugmakers Johnson & Johnson and Kenvue for deceptively marketing acetaminophen to pregnant mothers after President Donald Trump's claims th...

New York Magazine · 21h

Texas Sues Tylenol Following Trump Administration’s Unproven Autism Claims

PBS · 17h

Lawsuit by Trump ally Paxton asserts unproven claim of autism risk from acetaminophen

17hon MSN

Embattled Tylenol Maker Kenvue Hires New Marketing Chief

The company plans to name snack food executive Jon Halvorson as it faces a crisis over concerns of links between Tylenol and autism.

Renaissance Capital Bets Big on Tylenol and Kenvue (KVUE) By Purchasing Over 351,000 Shares

Renaissance Capital's bet on Kenvue is a bold one. The stock has performed poorly since the consumer health business spun off from Johnson & Johnson in 2023. At recent prices, the stock has lost about 45% of its value since its market debut a couple of years ago.

Time To Buy The Dip In Kenvue Stock?

Kenvue (NYSE:KVUE), the consumer healthcare spin-off from Johnson & Johnson, has experienced a significant decline in its stock price in recent months.